Daily non-political popular news in brief.
Stanford researchers get precise picture of cell target for drugs
10-25-2007 · EurekAlert!More than half of all drugs given to patients work by targeting a particular type of "docking station," or receptor, found on body cells, to steer the cell's machinery toward healing an illness. Researchers from Stanford University School of Medicine and the Scripps Research Institute have determined what one of those receptors looks like at the molecular level, giving them the keys to greater control of the process.
Read more »
Keywords: stanford, researchers, precise, picture, cell, target, drugs, researcher, drug
« Previous | Next »
Similar news on "Stanford researchers get precise picture of cell target for drugs":
- Cell skeleton may hold key to overcoming drug resistance in cancer
10-03-2007 · EurekAlert!
Researchers have uncovered a new way in which a cell protein protects cancer cellsfrom a wide range of chemotherapeutic drugs, identifying a possible target forimproving treatment outcomes for patients.
Similar news · Read more »
- New target for anti-flu drug development
08-15-2007 · EurekAlert!
Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Mass., in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-flu drugs, including those that may be effective against potentially pandemic influenza strains like H5N1. The findings have been published in the Aug. 15, 2007, issue of the journal Cell Cycle. A figure from their paper was selected for the journal cover.
Similar news · Read more »
- Gene expression profiling of dengue virus infection in cell lines and patients
11-06-2007 · EurekAlert!
Researchers at the Novartis Institute for Tropical Diseases and the Genome Institute of Singapore have identified new host genes associated with dengue virus infection, which may open new avenues to developing a drug to treat the disease. The results suggest that drugs that target the host pathways may prove effective against dengue.
Similar news · Read more »
- Jefferson scientists identify protein key to breast cancer spread, potential new drug target
04-09-2007 · EurekAlert!
Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread. The finding, reported online the week of April 9, 2007, in the journal Proceedings of the National Academy of Sciences, could be a potential target for new drugs aimed at stopping or slowing the growth and progression of breast cancer.
Similar news · Read more »
- Mutation improves memory, may lead to memory-enhancing pill
04-05-2007 · EurekAlert!
A mind-altering mutation in mice results in an enhanced long-term memory, researchers report in the April 6, 2007, issue of the journal Cell, published by Cell Press. These findings point to a potential target for the development of a drug to treat memory loss, according to the researchers.
Similar news · Read more »
- Brown researchers make major signal transduction discovery
10-04-2007 · EurekAlert!
How cells sense and respond to chemical messages -- a process known as signal transduction -- is a fundamental force in biology, controlling key processes such as cell growth and immune response. Now researchers from the Warren Alpert Medical School of Brown University and Rhode Island Hospital report a significant discovery in the field of signal transduction that could provide a new target for drugs that fight cancer, HIV and diseases. Results are published in Cell.
Similar news · Read more »
- Lung cancer cells' survival gene seen as drug target
12-31-2007 · EurekAlert!
When a key gene called 14-3-3zeta is silenced, lung cancer cells can't survive on their own, researchers have found. The gene is a potential target for selective anticancer drugs.
Similar news · Read more »
- Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss
10-05-2006 · ScienceDaily
A drug designed to target a powerful hunger-stimulating factor that has long been considered a prime target for antiobesity therapy failed to produce clinically meaningful weight loss in obese people in a long-term clinical trial. People taking the drug known as MK-0557 for a year consistently lost about three pounds more than those taking a placebo, researchers reported in the October issue of the journal Cell Metabolism, published by Cell Press.
Similar news · Read more »
- Support for chromosomal theory of cancer found in cancers' development of drug resistance
06-27-2007 · EurekAlert!
Most cancer researchers are convinced that cancer results from a handful of genetic mutations that kick a cell into uncontrolled growth. UC Berkeley genetics researcher Peter Duesberg disagrees, and finds support for his "chromosomal" theory of cancer in the development of drug resistance by many cancers. While his theory implies their is no magic bullet against cancer, it does provide ways to detect cancer at an early stage.
Similar news · Read more »
- Study of drug therapy for compulsive buying yields a puzzle, Stanford researcher says
03-13-2007 · EurekAlert!
Researchers at the Stanford University School of Medicine say they are puzzled by findings from their new study indicating that an antidepressant, which previously showed promise in treating a behavioral disorder known as compulsive buying, did not result in a sustained benefit for the patients who took it.
Similar news · Read more »
